Cargando…

Modifiable Risk Factors for Alzheimer’s Disease

Since first described in the early 1900s, Alzheimer’s disease (AD) has risen exponentially in prevalence and concern. Research still drives to understand the etiology and pathogenesis of this disease and what risk factors can attribute to AD. With a majority of AD cases being of sporadic origin, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Edwards III, George A., Gamez, Nazaret, Escobedo Jr., Gabriel, Calderon, Olivia, Moreno-Gonzalez, Ines
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601685/ https://www.ncbi.nlm.nih.gov/pubmed/31293412 http://dx.doi.org/10.3389/fnagi.2019.00146

Ejemplares similares

Editorial: Risk Factors for Alzheimer's Disease
por: Moreno-Gonzalez, Ines, et al.
Publicado: (2020)

Aged Cattle Brain Displays Alzheimer's Disease-Like Pathology and Promotes Brain Amyloidosis in a Transgenic Animal Model
por: Moreno-Gonzalez, Ines, et al.
Publicado: (2022)

Amyloid pathology arrangements in Alzheimer’s disease brains modulate in vivo seeding capability
por: Duran-Aniotz, Claudia, et al.
Publicado: (2021)

Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer’s disease
por: Salvadores, Natalia, et al.
Publicado: (2022)

Transmission of cerebral amyloid pathology by peripheral administration of misfolded Aβ aggregates.
por: Morales, Rodrigo, et al.
Publicado: (2021)

Peripheral Delivery of Neural Precursor Cells Ameliorates Parkinson’s Disease-Associated Pathology
por: Edwards, George, et al.
Publicado: (2019)

Metabolic Abnormalities of Erythrocytes as a Risk Factor for Alzheimer's Disease
por: Kosenko, Elena A., et al.
Publicado: (2018)

Histone Acetylation Modifiers in the Pathogenesis of Alzheimer’s Disease
por: Lu, Xi, et al.
Publicado: (2015)

Huperzine A: Is it an Effective Disease-Modifying Drug for Alzheimer’s Disease?
por: Qian, Zhong Ming, et al.
Publicado: (2014)

The MAPT H1 Haplotype Is a Risk Factor for Alzheimer’s Disease in APOE ε4 Non-carriers
por: Sánchez-Juan, Pascual, et al.
Publicado: (2019)

Menopause, obesity and inflammation: interactive risk factors for Alzheimer’s disease
por: Christensen, Amy, et al.
Publicado: (2015)

The impact of Alzheimer’s disease risk factors on the pupillary light response
por: Sparks, Sierra, et al.
Publicado: (2023)

Mechanisms of Risk Reduction in the Clinical Practice of Alzheimer’s Disease Prevention
por: Schelke, Matthew W., et al.
Publicado: (2018)

Matrix disequilibrium in Alzheimer’s disease and conditions that increase Alzheimer’s disease risk
por: Amontree, Matthew, et al.
Publicado: (2023)

Insulin Signaling Impairment in the Brain as a Risk Factor in Alzheimer’s Disease
por: Hölscher, Christian
Publicado: (2019)

Obesity as a Risk Factor for Alzheimer’s Disease: Implication of Leptin and Glutamate
por: Lloret, Ana, et al.
Publicado: (2019)

Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases
por: Chin-Chan, Miguel, et al.
Publicado: (2015)

Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease Dementia
por: Ettcheto, Miren, et al.
Publicado: (2020)

Transfer learning-based modified inception model for the diagnosis of Alzheimer's disease
por: Sharma, Sarang, et al.
Publicado: (2022)

Longitudinal Assessment of Tau-Associated Pathology by (18)F-THK5351 PET Imaging: A Histological, Biochemical, and Behavioral Study
por: Moreno-Gonzalez, Ines, et al.
Publicado: (2021)

Oxidative Stress Mediates the Pathogenic Effect of Different Alzheimer's Disease Risk Factors
por: Guglielmotto, Michela, et al.
Publicado: (2010)

Homocysteine and Folic Acid: Risk Factors for Alzheimer's Disease—An Updated Meta-Analysis
por: Wang, Qianwen, et al.
Publicado: (2021)

Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer’s Disease
por: Vinuesa, Angeles, et al.
Publicado: (2021)

Editorial: Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease
por: Gao, Xiaoya
Publicado: (2023)

Disease-modifying treatments in Alzheimer’s disease
por: Edwards, Marc, et al.
Publicado: (2023)

Changes in Adiposity and Cerebrospinal Fluid Biomarkers Following a Modified Mediterranean Ketogenic Diet in Older Adults at Risk for Alzheimer’s Disease
por: Brinkley, Tina E., et al.
Publicado: (2022)

Antibody Engineering for Optimized Immunotherapy in Alzheimer's Disease
por: Sumner, Isabelle L., et al.
Publicado: (2018)

Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease
por: Luo, Jiao, et al.
Publicado: (2023)

Editorial: How does exercise modify the course of Alzheimer's disease?
por: Arciero, Paul J., et al.
Publicado: (2023)

Novel Alzheimer risk factor IQ motif containing protein K is abundantly expressed in the brain and is markedly increased in patients with Alzheimer’s disease
por: Wang, Hongjie, et al.
Publicado: (2022)

Possible modification of Alzheimer’s disease by statins in midlife: interactions with genetic and non-genetic risk factors
por: Shinohara, Mitsuru, et al.
Publicado: (2014)

Isometric Exercise Training for Managing Vascular Risk Factors in Mild Cognitive Impairment and Alzheimer’s Disease
por: Hess, Nicole C. L., et al.
Publicado: (2017)

Crosstalk between Cdk5 and GSK3β: Implications for Alzheimer's Disease
por: Engmann, Olivia, et al.
Publicado: (2009)

Editorial: Additive or synergistic impacts of sleep, circadian rhythm disturbances and other modifiable risk factors on established and novel plasma biomarkers of Alzheimer's disease pathology
por: Bubu, Omonigho M., et al.
Publicado: (2023)

Sex and Gender Driven Modifiers of Alzheimer’s: The Role for Estrogenic Control Across Age, Race, Medical, and Lifestyle Risks
por: Rahman, Aneela, et al.
Publicado: (2019)

Targeting Beta-Amyloid at the CSF: A New Therapeutic Strategy in Alzheimer’s Disease
por: Menendez-Gonzalez, Manuel, et al.
Publicado: (2018)

Identifying Vulnerable Brain Networks in Mouse Models of Genetic Risk Factors for Late Onset Alzheimer’s Disease
por: Badea, Alexandra, et al.
Publicado: (2019)

Ammonia as a Potential Neurotoxic Factor in Alzheimer's Disease
por: Adlimoghaddam, Aida, et al.
Publicado: (2016)

Impact of transcranial direct current stimulation on white matter microstructure integrity in mild cognitive impairment patients according to effect modifiers as risk factors for Alzheimer’s disease
por: Kang, Dong Woo, et al.
Publicado: (2023)

The Role of Circulating Aβ Seeds in the Progression of Cerebral Amyloidosis
por: Gamez, Nazaret, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sennsbe1q9qr8u73k3c8j1peec